Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Biotechnology > Genome-based Drug Discovery > Technology Developments in Functional Proteomics
Category
Biotechnology (1524)
Antibody & Immunity (193)
Biomarker (168)
Biomaterials (56)
Biotechnology Equipment (349)
Gene Therapeutics & RNAi (104)
Genome-based Drug Discovery (204)
Molecular Targeted Therapeutics (51)
Personalized Medicine (57)
Regenerative Medicine (122)
Market Research Report

Technology Developments in Functional Proteomics

Published by Technical Insights, Inc.
Published September, 2006 Product code 45455
Content info 144 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


Technology Developments in Functional Proteomics published by Technical Insights, Inc. in September, 2006. This report consists of 144 Pages and the price starts from US $ 6000.

Introduction

Abstract

Outlines global innovation and technology development in the field of functional proteomics.

Table of Contents

1 EXECUTIVE SUMMARY

  • Introduction
    • Introduction
    • Noteworthy Applications
    • Market Trends
    • Noteworthy Emerging Technologies
  • Scope and Methodology
    • Scope
    • Methodology

2 TECHNOLOGY AND APPLICATIONS VIEWPOINT

  • Technology Primer--Proteomics Technologies
    • Proteomics Techniques--General
    • Proteomic Techniques--Functional Proteomics
    • Functional Proteomic Approaches
    • Additional Approaches
  • Applications Analysis and Trends
    • Antibodies as Therapeutics

3 TECHNOLOGY IMPACT ANALYSIS

  • Assessment of Stakeholder Innovation and Technology Transfer Opportunities
    • Introduction
    • Noteworthy Innovation at Key Companies
    • Noteworthy Innovation at Key Academic and Government-Related Institutions
  • Influential Market Factors and Industry Trends
    • Mergers & Acquisition Activity
    • Regulatory and Political or Other Factors
    • Industry Trends

4 TECHNOLOGY ADOPTION FACTOR ANALYSIS

  • Primary Challenges
    • Technology or Product Development Restraints
    • Competing Technologies
  • Analysis of Market Drivers
    • Analysis of Funding Sources
    • Features and Advantages of Functional Proteomics
    • Enabling Technologies
    • Adoption Drivers for Functional Proteomics

5 ASSESSMENT OF INNOVATION AND OPPORTUNITIES

  • Assessment of Innovation in North America--Companies
    • Phosphoprotein Profiling Platform I.D. Cancer-Drug Target
    • In Vitro Molecular Imaging Tool Directly Images Protein Biomarkers
    • ProteinChip Chromatographic Array System Relates Proteins to Disease
    • Microarrays and Gold Balls I.D. Proteins Better than ELISA
    • High-Content Screening
    • TWEAK Pathway Plays Role in Arthritis
    • Tyrosine Kinase Mutant Associated with AML
    • Recombinant Proteins with Human Glycosylation From Yeast
    • Additional Companies
  • Assessment of Innovation in North America--Government and Academic Research Institutions
    • Multicolor Color BiFC Assays Developed by Purdue University
    • Nature' s Most Resilient Nanosprings
    • Biosensor Dye Aid Viewing Proteins in Live Cells
    • Lab-On-Chip Analyzes One Cell at a Time
    • Linking Enzyme Sequence to Function
    • Second Function Found for Cell-Cycle Regulatory Protein
    • Mitochondrial Protein Also Helps Cells Fend off Viruses
    • Modified E. Coli Make Human Glycoproteins
    • Signalling Protein Acts in Nucleus; Not Just in Cytoplasm
    • SMS Nanoprobe Could Lead to Better Diagnosis; Drug Design
  • Assessment of Innovation in Europe
    • Companies
    • Additional Companies
    • Government and Academic Research Institutions
  • Assessment of Innovation in the Asia Pacific Region
    • Companies
    • Government and Academic Research Institutions

6 PATENTS AND CONTACTS

  • Patents
    • Patents
  • Contacts
    • Contacts

7 DECISION SUPPORT DATABASE

  • R&D Expenditure
    • Pharmaceutical R&D Expenditure--World (2002 to 2012)
    • Percentage of Pharmaceutical R&D Expenditure--World (2002 to 2012)
  • Biotechnology Investment
    • Government Investment in Biotech R&D--World (2002 to 2012)
    • Venture Capital Investment in Biotech R&D--World (2002 to 2012)
Back to Top